[The non-hormonal treatment of metastatic prostate cancer]. [electronic resource]
- Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie Nov 2013
- 1258-64 p. digital
Publication Type: Journal Article; Review
1166-7087
10.1016/j.purol.2013.08.322 doi
Antibodies, Monoclonal, Humanized--therapeutic use Antineoplastic Agents--economics Bone Density Conservation Agents--therapeutic use Cisplatin--economics Denosumab Docetaxel Etoposide--economics Humans Male Mitoxantrone--economics Organometallic Compounds--economics Organophosphorus Compounds--economics Osteoporosis--etiology Prostatic Neoplasms--pathology RANK Ligand--antagonists & inhibitors Radiation Protection--methods Radioisotopes--economics Radium--economics Strontium--economics Strontium Radioisotopes--economics Taxoids--economics